MORE►
UT Southwestern Medical Center
Dr. Brett Giroir is CEO of OncoNano Medicine. [Photo: OncoNano]
OncoNano Names Public Health Leader and Board Chairman as CEO
by Sandra Engelland | Nov 12, 2026
Dr. Brett Giroir, who has served as interim CEO since May, will take the lead on advancing the Dallas-based company’s targeted cancer therapies.
by Sandra Engelland |
Aug 27, 2026
Grants of $100,000 or $200,000 went to research projects not chosen for the 2026 Hill Prizes. Six Texas researchers, including three from Dallas’ UT Southwestern Medical Center, shared the $1 million.
MORE►
Rendering of Stephens Greth Tower at the new Moody Children's Hospital [Image via UTSW]
UTSW, Children’s Health Get $100M From Stephens Greth Foundation for $5B Pediatric Campus
by Sandra Engelland | Apr 1, 2026
A tower under construction at the new Moody Children’s Hospital in Dallas will be named Stephens Greth Tower in recognition of the gift, which is the fourth nine-figure gift given to the hospital project to date.
MORE►
by Maddie Preston |
Jan 13, 2026
The project, known as Vascularized Immunocompetent Tissue as an Alternative Liver, or VITAL, aims to "biofabricate" functioning livers using patients' own cells and advanced 3D printing techniques.
MORE►
by Quincy Preston |
Oct 15, 2025
Researchers at UTSW identified a set of neurons in the "brain's timekeeper" that may drive nighttime snacking—and in mice, control up to 7% of body weight. The discovery could pave the way for new weight-loss strategies.
MORE►
by Lance Murray |
Sep 18, 2025
UT Southwestern in Dallas will lead three liver cancer projects on prevention, recurrence, and immunotherapy. It joins Mayo Clinic and MD Anderson as a national NCI SPORE site, a program that moves discoveries into clinical trials.
MORE►
Eric Olson, Ph.D. [Photo: UTSW]
UTSW Molecular Biologist Wins Prestigious Columbia Prize for Work on Duchenne Muscular Dystrophy
by Lance Murray | Sep 9, 2025
Eric Olson has spent decades dedicated to what he calls “the biggest prize of all”: a cure for the devastating disease. Nearly half of the scientists awarded Columbia’s Horwitz Prize over the past 58 years went on to win a Nobel, UTSW said.
MORE►
by David Seeley |
Aug 19, 2025
Part of the 2025 iC³ Life Science & Healthcare Innovation Summit to be held September 16-17 in Dallas, the showcase pitch event is designed to connect university researchers with potential investors, industry executives, and strategic partners. This is the first year the showcase has expanded beyond Texas.
MORE►
by Lance Murray |
Aug 18, 2025
The Dallas-based firm will provide program management and oversee construction activity for the new medical campus from Children’s Health and UT Southwestern.
MORE►
by Maddie Preston |
Aug 8, 2025
The funding supports UT Arlington researcher Junzhou Huang, whose team recently ranked first in protein contact prediction and placed sixth overall in an international AI challenge competing against Google DeepMind, the University of Washington, and others.
MORE►
In this image, the proteasome—a cell’s protein disposal system—is shown in tan and grey. A protein called midnolin (in red) connects with two key parts of the proteasome, RPN1 (blue) and RPN11 (green), to help deliver damaged or unwanted proteins for breakdown. This interaction helps keep cells healthy by clearing out the cellular junk. [Image: UTSW]
UT Southwestern Maps a Cancer-Enabling Protein That Lets B-Cell Tumors Hang On—With a Nobel Laureate on the Case
by Lance Murray | Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
by Lance Murray |
Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
by Lance Murray |
May 25, 2025
The Dallas-based medical center is one of just two in Texas offering osseointegration, a revolutionary implant technique that gives amputees better control, comfort—and for 50-year-old Scott Bryson, the chance to walk his daughter down the aisle.
MORE►
by Lance Murray |
May 6, 2025
To recognize the foundation's "record-breaking" support, the hospital at the new Dallas pediatric campus will be named Moody Children's Hospital upon completion in 2031.
MORE►
